Soluble Receptor of Transferrin (sTfR) as a Marker of Iron Deficiency in Inflammatory Conditions

Abstract

Get full access to this article

View all access options for this article.

References

Liu

Ren

Hong

. Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn’s disease: a prospective cohort study. Nutr Clin Pract. 2013;28(1):120-127.

Clark

. Iron deficiency anemia. Nutr Clin Pract. 2008;23(2):128-141.

Gabay

Kushner

. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454.

Speeckaert

Delanghe

. Biological and clinical aspects of soluble transferrin receptor. Crit Rev Clin Lab Sci. 2010;47(5-6):213-228.

Beguin

. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta. 2003;329(1-2):9-22.

Marković

Majkić-Singh

Subota

. Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease. Scand J Clin Lab Invest. 2005;65(7):571-576.

Meng

Zhu

Yang

Wang

. Erythropoietin inhibits gluconeogenesis and inflammation in the liver and improves glucose intolerance in high-fat diet-fed mice. PLoS One. 2013;8(1):e53557.